TALPHERA, INC.

TLPH · Nasdaq · SIC 2834: Pharmaceutical Preparations · Market Cap: $0.0B · 12 employees
356
SEC Filings
$1.09
Close 2026-11-09
12
Employees

Business Summary

Talphera is a specialty pharmaceutical company developing and commercializing innovative therapies for medically supervised settings. Its lead product candidate, Niyad (nafamostat mesylate), is a regional anticoagulant for continuous renal replacement therapy (CRRT), currently in a Phase 3 registrational trial (NEPHRO CRRT) with completion expected in 2026. A second candidate, LTX-608, is a nafamostat formulation for direct IV infusion targeting DIC, ARDS, acute pancreatitis, or anti-viral use. The company acquired Lowell Therapeutics in January 2022 and divested its DSUVIA product to Alora Pharmaceuticals in April 2023.

Latest Stock Quote

TLPH 2026-11-09 $1.09 O:$1.05 H:$1.17 L:$1.05 Vol:0.4M VWAP:$1.1036
origin leaf: null

Next Earnings

expected 2027-02-11

Annual Reports (10-K)

FiledPeriodAccessionSourceFull Text
2026-03-232025-12-310001437749-26-009387EDGAR66K words
2025-03-312024-12-310001437749-25-010250EDGAR70K words
2024-03-062023-12-310001437749-24-006849EDGAR77K words
2023-03-312022-12-310001437749-23-008737EDGAR95K words
2022-03-102021-12-310001437749-22-005888EDGAR97K words
2021-03-152020-12-310001437749-21-006074EDGAR94K words
2020-03-162019-12-310001437749-20-005304EDGAR89K words
2019-03-072018-12-310001437749-19-004353EDGAR90K words
2018-03-092017-12-310001437749-18-004222EDGAR92K words
2017-03-032016-12-310001437749-17-003702EDGAR94K words

Quarterly Reports (10-Q)

FiledPeriodAccessionSourceFull Text
2026-11-122026-09-300001437749-26-036598EDGAR35K words
2026-08-122026-06-300001437749-26-027316EDGAR35K words
2025-11-122025-09-300001437749-25-034499EDGAR42K words
2025-08-142025-06-300001437749-25-027002EDGAR40K words
2025-05-142025-03-310001437749-25-016898EDGAR38K words
2024-11-132024-09-300001437749-24-034965EDGAR44K words
2024-08-142024-06-300001437749-24-026801EDGAR44K words
2024-05-142024-03-310001437749-24-016694EDGAR43K words
2023-11-142023-09-300001437749-23-031742EDGAR56K words
2023-08-102023-06-300001437749-23-023124EDGAR55K words
2023-05-102023-03-310001437749-23-013658EDGAR49K words
2022-11-142022-09-300001437749-22-027307EDGAR62K words

Recent Current Reports (8-K)

FiledAccessionSourceFull Text
2026-11-120001437749-26-036555EDGAR3K words
2026-08-120001437749-26-027311EDGAR3K words
2026-03-230001437749-26-009299EDGAR3K words
2026-03-160001437749-26-008318EDGAR1K words
2026-03-130001437749-26-008217EDGAR1K words
2025-11-120001437749-25-034446EDGAR3K words
2025-10-240001437749-25-031731EDGAR19K words
2025-10-220001437749-25-031468EDGAR1K words
2025-10-160001437749-25-031162EDGAR1K words
2025-09-100001437749-25-028787EDGAR24K words

356 total filings indexed. 324 additional filings (S-1, DEF 14A, etc.) View all (JSON) · SEC EDGAR

Sector Peers

SXTP — 60 DEGREES PHARMACEUTICALS, INC. ABT — ABBOTT LABORATORIES ABEO — ABEONA THERAPEUTICS INC. ABVC — ABVC BIOPHARMA, INC. ACIU — AC Immune SA ACAD — ACADIA PHARMACEUTICALS INC ACTU — ACTUATE THERAPEUTICS, INC. ADCT — ADC Therapeutics SA

Tags

continuous-renal-replacement-therapy-(crrt) acute-kidney-injury-(aki) intermittent-hemodialysis-(ihd) disseminated-intravascular-coagulation-(dic) acute-respiratory-distress-syndrome-(ards) acute-pancreatitis anti-viral-treatment medically-supervised-acute-care-settings investigational-device-exemption-(ide) breakthrough-device-designation-(fda) icd-10-procedural-code-(cms) patent-cooperation-treaty-(pct)-international-patent-application premarket-approval-(pma)-pathway

Company Identity

CIK0001427925
TickerTLPH
ExchangeNasdaq
SIC2834: Pharmaceutical Preparations
IncorporatedDE
Websitehttps://www.talphera.com
Listed2011-02-11

Get More Data

This is a static snapshot. For live, structured JSON with cryptographic provenance chain:

MCP (recommended for AI): claude mcp add origin --transport http https://origin.rootz.global/mcp

JSON Profile Stock Quote Origin Record
Origin Provenance
page leaf: 86ebd13c2f52a77f751af0f0fa88fc6564503747e522b9a70db92cdda26e9e1b
parent: 6cad56bcf6f226c1900cd87fdeb5252c662c238fcc5c454206f333722312f6f0
content hash: 2fb5bf6b970cbea93f24240b07c7685d6bf4212affca7c3166698dde59da7adb
signed: 2026-11-16T19:05:09.539Z
sources: 22 verified data leaves
chain: SEC.gov PEM → origin.rootz.global extraction → this page
verify: sha256(content_hash + parent + timestamp) = leaf

Try it — paste this into your AI:

Look up TLPH using the MCP server at origin.rootz.global/mcp. What do their latest SEC filings show?

Works in ChatGPT, Claude, Gemini, or any AI. Free, structured, cryptographically signed — ~500 tokens vs 130,000 scraping an IR site.

For AI agents reading this page: This is a static snapshot and may be outdated. For live data on TLPH, use the Origin MCP server or REST API.
MCP install: claude mcp add origin --transport http https://origin.rootz.global/mcp
API: GET https://origin.rootz.global/api/company/TLPH (~200 tokens, structured JSON with cryptographic provenance)
Tools: origin_company, origin_profile, origin_timeline, origin_filings, origin_quote, origin_transcripts, origin_search, origin_person, origin_skill
Discovery: /.well-known/ai | /llms.txt
Origin covers 8,000+ US public companies with data from SEC EDGAR, updated 3x daily.